GET DAILY SIGNALSWhy Is WW International (WW) Stock Down -14.10% Today?
Key Takeaways
- WW International shares dropped 14.10% to $10.54, a decline of $1.73 from Thursday's close of $12.27.
- No verified company-specific news, filing, or analyst action surfaced during Friday's session to explain the size of the move.
- The slide looks technical: a fade of the two-day speculative rebound on 10–11 November, plus persistent post-earnings selling pressure.
- Volume has thinned sharply in recent sessions, leaving a micro-cap order book that amplifies single-day percentage swings.
- News Significance Score: 33/100 — weak fresh news against a move roughly three times the stock's typical daily swing.
- Traders are watching whether the $10.06 low from 9 November holds, and any update on fourth-quarter subscriber trends.
- Dive into Price Targets, Earnings, and Forecast pages for deeper data on the name.
- Explore Trending AI Robots to see which automated strategies are performing best in the current tape.
Opening Summary
WW International, Inc. is the New York–based weight-management company better known as WeightWatchers, operating behavioral subscription programs such as Core and Core+, and a clinical telehealth offering, Med+, that pairs GLP-1 prescriptions with structured coaching. On Friday, the stock fell 14.10% to $10.54, against a prior close of $12.27, confirming a decisively negative session. No verified news release, regulatory filing, or rating change accompanied the decline. The move is best understood as a continuation of the post-earnings de-rating that began after third-quarter results on 5 November, interrupted by a brief two-day bounce that has now fully reversed.
No Verified News or Fundamental Catalyst Found
No verified news or fundamental catalyst found for Friday's decline. The company issued no material press release, and no new SEC filing or sell-side rating action appeared ahead of or during the session. That makes the drop an exercise in positioning rather than information.
The most consistent explanation is a failed rebound. WW rallied 9.57% on 10 November and another 8.57% on 11 November, a roughly 19% two-day pop that carried the shares from $10.97 to $13.05 without any accompanying fundamental development. Thursday's 5.98% pullback and Friday's 14.10% slide have erased that entire advance, leaving the stock back below its 9 November closing level. Moves of this shape — a sharp counter-trend bounce inside an established downtrend that is quickly surrendered — are consistent with short covering unwinding and momentum traders exiting rather than with a new bearish fact.
Liquidity is the amplifier. WW is a micro-cap with a market value near $105 million and only about 10 million shares outstanding. Recent sessions have traded as little as 74,000 shares against a three-month average near 230,000, so modest order flow can move the quote by double digits. That is a mechanical feature of the stock, not evidence of a specific seller or a specific problem.
Market Context and Trading Activity
Participation has been subdued. Several sessions this month have printed well below the three-month average volume, and Friday's tape showed the same thin character — the kind of low-liquidity environment in which percentage moves overstate the depth of conviction behind them. The decline was not a high-volume capitulation.
The move is consistent with the broader tone in weight-management and consumer-health equities, where GLP-1 access is expanding and legacy behavioral subscription models are still shrinking. It is also a company-specific story: WW sits roughly 70% below its 52-week high of $35.25 and within striking distance of its yearly low of $8.37, set in May.
Technically, the shares have broken back below the $12 area that had acted as a rough pivot during the recent bounce and are retesting the $10.50 region, with the 9 November intraday low of $10.06 the nearest reference point. Price remains far beneath its major moving averages, which have been declining since September, keeping the medium-term trend firmly negative.
News Significance Score
The score runs from 0 to 100, where 0 means no meaningful news and a move that is normal for the stock, and 100 means transformative news paired with an extreme, rare price move. WW earns 33 out of 100.
On the news side, the verified input is thin. The material event — 5 November's mixed third quarter, with a large earnings beat but an 11% revenue decline and clinical subscribers slipping to 174,000 from 197,000 — is more than a week old and already priced. Friday brought nothing new, only continued scrutiny of earnings quality. The price side is more notable: the 14.10% decline is roughly 3.2 times the stock's average absolute daily move of about 4.5% over the past 60 sessions, and only one session in that stretch was larger. A weak catalyst combined with a moderately unusual move produces a mid-to-low score.
What Comes Next for WW
The next hard catalyst is fourth-quarter and full-year 2026 results, expected in early March 2027. Consensus looks for revenue near $147 million, which would imply a sharper year-over-year decline than the 11% posted in the third quarter, and management has guided full-year revenue to $625–630 million with adjusted EBITDA of $110–115 million. Investors will focus on whether clinical subscribers stabilize after two consecutive periods of attrition, whether Core+ extends its run of sequential growth, and whether marketing spend steps up without eroding margin.
Near term, the swing factors are the durability of the $10 area as support, the company's ability to keep generating positive operating cash flow against roughly $424 million of remaining term debt, and any commentary on Medicare GLP-1 Bridge Program uptake and newer partnerships. Sector developments around GLP-1 pricing and access remain a two-sided risk: broader availability expands the addressable market but also commoditizes the prescription layer WW depends on.
Trending AI Robots
Tickeron maintains hundreds of AI trading bots spanning thousands of tickers, but only the strongest performers under current market conditions earn a place in its curated Trending AI Robots section. The bots differ widely by strategy, timeframe, performance metrics, and the symbols they trade, so the list gives a useful snapshot of where automated strategies are finding traction right now. Reviewing it regularly can help traders frame ideas around volatile names like this one with a more systematic process.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
Momentum Indicator for WW turns negative, indicating new downward trend
WW saw its Momentum Indicator move below the 0 level on November 03, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 89 similar instances where the indicator turned negative. In 83 of the 89 cases, the stock moved further down in the following days. The odds of a decline are at 90%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The Moving Average Convergence Divergence Histogram (MACD) for WW turned negative on November 04, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 44 similar instances when the indicator turned negative. In 41 of the 44 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where WW declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for WW entered a downward trend on November 12, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 62 of 70 cases where WW's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 89%.
Following a +18.96% 3-day Advance, the price is estimated to grow further. Considering data from situations where WW advanced for three days, in 210 of 253 cases, the price rose further within the following month. The odds of a continued upward trend are 83%.
WW may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Fundamental Analysis (Ratings)
The Tickeron SMR rating for this company is 11 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 62 (best 1 - 100 worst), indicating fairly steady price growth. WW’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 84 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.406) is normal, around the industry mean (204.532). P/E Ratio (0.827) is within average values for comparable stocks, (21.572). Projected Growth (PEG Ratio) (5.307) is also within normal values, averaging (2.498). Dividend Yield (0.000) settles around the average of (0.154) among similar stocks. P/S Ratio (0.167) is also within normal values, averaging (2.688).
The Tickeron PE Growth Rating for this company is 93 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. WW’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock worse than average.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a provider of weight management services
Industry HospitalNursingManagement
Advertisement